|
시장보고서
상품코드
1457952
절제 기술 시장 : 시장 규모, 점유율 분석, 산업 수요 예측(-2030년)Ablation Technology Market Size and Share Analysis by Product, Application, End User - Global Industry Demand Forecast to 2030 |
||||||
세계의 절제 기술(Ablation Technology) 시장은 2023년에 53억 1,320만 달러였으며, 2024년부터 2030년까지 9.0%의 CAGR로 성장할 것으로 예측되고 있습니다. 이러한 성장으로 2030년 시장 규모는 96억 7,290만 달러에 달할 것으로 예상됩니다.
이 발전의 배경은 심장병, 암, 안과, 부인과, 비뇨기과 질환과 같은 만성 질환의 환자 수의 급증이 있습니다. 그 결과, 효율적인 수술 치료의 필요성이 증가하고, 절제 장치에 대한 수요가 증가하고 있습니다.
고주파 절제가 시장을 독점
고주파 절제 부문은 2023년에 25%로 가장 큰 점유율을 차지했습니다. 또한 예측 기간 중 CAGR은 9.2%로 예측됩니다.
양성 종양과 종양 종양, 만성 목과 허리 통증, 다리의 만성 정맥 결핍증과 같은 일부 치료에 RFA가 사용되고 있습니다. 있기 때문입니다.
절제 기술은 심혈관 치료에 가장 많이 사용됩니다.
심장혈관 카테고리는 2023년에 응용 분야에서 가장 큰 점유율을 차지했습니다.
절제 기술은 심방 세동의 치료에 널리 사용되며 불규칙한 심박동을 일으키는 불규칙한 전기 신호를 파괴하는 데 도움이 됩니다.
북미가 시장에서 가장 큰 점유율을 차지
2023년 북미는 절제 기술 산업에서 가장 큰 시장이었습니다. 이는 이 기술의 성장과 많은 치료에 대한 응용에 대한 지식 증가 때문입니다.
예측 기간 동안 아시아 태평양은 9.5%의 CAGR로 가장 빠르게 성장합니다. 이는 최소 침습적 방법에 대한 지식의 급증, 의료제도의 발전, 경제 성장 때문입니다.
세계의 절제 기술(Ablation Technology) 시장에 대해 분석했으며, 시장의 기본 구조, 최신 정세, 주요한 촉진·억제 요인, 세계 전체 및 지역별·주요 국가별 시장 규모 동향 전망(금액 기준, 2017-2030년)/제품별·용도별·최종 사용자별 상세 동향/현재 시장 경쟁 구도/주요 기업 프로파일 등 정보를 전해드립니다.
목차
제1장 조사 범위
제2장 조사 방법
제3장 주요 요약
제4장 시장 지표
제5장 산업 전망
- 시장 역학
- 동향
- 성장 촉진 요인
- 억제 요인/과제
- 성장 촉진 요인/억제 요인의 영향 분석
- COVID-19의 영향
- Porter's Five Forces 분석
제6장 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 최종 사용자별(2017-2030년)
- 시장 매출 : 지역별(2017-2030년)
제7장 북미 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 최종 사용자별(2017-2030년)
- 시장 매출 : 국가별(2017-2030년)
제8장 유럽 시장
제9장 아시아 태평양 시장
제10장 남미 시장
제11장 중동 및 아프리카(MEA) 시장
제12장 미국 시장
- 개요
- 시장 매출 : 제품별(2017-2030년)
- 시장 매출 : 용도별(2017-2030년)
- 시장 매출 : 최종 사용자별(2017-2030년)
제13장 캐나다 시장
제14장 독일 시장
제15장 프랑스 시장
제16장 영국 시장
제17장 이탈리아 시장
제18장 스페인 시장
제19장 일본 시장
제20장 중국 시장
제21장 인도 시장
제22장 호주 시장
제23장 한국 시장
제24장 브라질 시장
제25장 멕시코 시장
제26장 사우디아라비아 시장
제27장 남아프리카 시장
제28장 아랍에미리트(UAE) 시장
제29장 경쟁 구도
- 시장 진출기업 및 제공 제품 및 서비스 목록
- 주요 기업의 경쟁 벤치마킹
- 주요 기업의 제품 벤치마킹
- 최근의 전략 전개 상황
제30장 기업 프로파일
- Medtronic plc.
- Johnson&Johnson Services Inc.
- Abbott Laboratories
- Boston Scientific Corporation
- Olympus Corporation
- Stryker Corporation
- Smith&Nephew plc
- Varian Medical Systems Inc.
- CONMED Corporation
- AngioDynamics Inc.
제31장 부록
LYJ 24.04.16The ablation technology market worldwide achieved revenue of USD 5,313.2 million in
2023, and it is anticipated to grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2030. This growth is expected to lead to a market size of USD 9,672.9 million by the year 2030.
The development can be credited to the surge in the count of cases of chronic diseases, like heart diseases, cancer, and ophthalmologic, gynecological, and urological diseases. As a result, there is an increased need for efficient surgical treatments, leading to higher demand for ablation devices.
Market Trends/Drivers
The increasing awareness regarding ablation procedures, growing healthcare spending, growing count of cancer cases, less cost of this procedure, and technical enhancements in related devices are the key reasons boosting the industry.
The growing count of hospitals and ambulatory operation centers is projected to fuel the development of the industry.
The growth in the ageing populace and surge in the need for minimally invasive procedures, credited to their benefits over the conventional, open procedures, will boost the product need.
Furthermore, minimally invasive methods provide precise results and are inexpensive for both care patients and providers. Moreover, the range of these procedures obtainable for different parts of the body, like brain surgeries, adrenalectomies, hiatal hernia repairs, colectomies, and nephrectomies, has made them enormously popular.
The Market Is Dominated by Radiofrequency Ablators
The radiofrequency ablators segment held the largest share, 25%, in 2023.
It is projected to experience a CAGR of 9.2% during the projection period.
This category is growing because of the growing utilization of RFA for several treatments like benign and oncogenic tumors, chronic neck and back pain, chronic venous deficiency in the legs, and more.
RFA is also used for treating atrial fibrillation, an irregular heartbeat condition.
FDA approvals for advanced radiofrequency ablators are expected to further boost the market.
Example: RF Medical Co. Ltd. received FDA clearance in December 2022 for its MYGEN M-3004 generator and MYOBLATE RFA system for use in the U.S.
Laser ablation also grips a substantial share in the industry, because of the research being done on this technology. In their January 2023 study, researchers showed that the co-administration of compression therapy with endovenous laser ablation positively impacted the rate of healing of venous ulcers and reduced the likelihood of recurrence.
Ablation Technology Founds Its Highest Usage in Cardiovascular Treatments
The cardiovascular category held the largest share in 2023 in terms of application.
Ablation technology is extensively used in treating atrial fibrillation, aiding in disrupting the irregular electrical signals responsible for irregular heartbeats.
Each cell in the myocardium generates its own signal for heartbeat, and when synchronization fails among cells, arrhythmia (irregular heartbeat) can result.
Ablation procedures are utilized to block the aberrant electric signals causing arrhythmias, restoring normal heart rhythm.
North America Held the Largest Share in the Market
In 2023, the North American region was the largest customer in the ablation technology industry, because of the growth in the technology and increasing knowledge about its applications in many treatments.
The surge in the count of patients who are suffering from chronic diseases mainly cancer is contributing to the development of the industry. Already, cancer is one of the top 10 foremost causes of demise in the nation. Its death rate is projected to surge to approximately 3 million by the end of 2040. also, approximately 37.3 million individuals in the nation were found to have diabetes, and about 96 million grownups were found to have pre-diabetes.
During the projection period, the Asia-Pacific region will be the fastest-rising ablation tech industry, with a CAGR of 9.5%. This can be credited to the surging knowledge regarding minimally invasive methods, growing healthcare systems, and rising economies.
Table of Contents
Chapter 1. Research Scope
- 1.1. Research Objectives
- 1.2. Market Definition
- 1.3. Analysis Period
- 1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by product
- 1.4.2. Market size breakdown, by application
- 1.4.3. Market size breakdown, by end user
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
- 1.5. Market Data Reporting Unit
- 1.5.1. Value
- 1.6. Key Stakeholders
Chapter 2. Research Methodology
- 2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
- 2.2. Primary Research
- 2.3. Market Size Estimation
- 2.4. Data Triangulation
- 2.5. Currency Conversion Rates
- 2.6. Assumptions for the Study
- 2.7. Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Market Indicators
Chapter 5. Industry Outlook
- 5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
- 5.2. Impact of COVID-19
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes
Chapter 6. Global Market
- 6.1. Overview
- 6.2. Market Revenue, by Product (2017-2030)
- 6.3. Market Revenue, by Application (2017-2030)
- 6.4. Market Revenue, by End User (2017-2030)
- 6.5. Market Revenue, by Region (2017-2030)
Chapter 7. North America Market
- 7.1. Overview
- 7.2. Market Revenue, by Product (2017-2030)
- 7.3. Market Revenue, by Application (2017-2030)
- 7.4. Market Revenue, by End User (2017-2030)
- 7.5. Market Revenue, by Country (2017-2030)
Chapter 8. Europe Market
- 8.1. Overview
- 8.2. Market Revenue, by Product (2017-2030)
- 8.3. Market Revenue, by Application (2017-2030)
- 8.4. Market Revenue, by End User (2017-2030)
- 8.5. Market Revenue, by Country (2017-2030)
Chapter 9. APAC Market
- 9.1. Overview
- 9.2. Market Revenue, by Product (2017-2030)
- 9.3. Market Revenue, by Application (2017-2030)
- 9.4. Market Revenue, by End User (2017-2030)
- 9.5. Market Revenue, by Country (2017-2030)
Chapter 10. LATAM Market
- 10.1. Overview
- 10.2. Market Revenue, by Product (2017-2030)
- 10.3. Market Revenue, by Application (2017-2030)
- 10.4. Market Revenue, by End User (2017-2030)
- 10.5. Market Revenue, by Country (2017-2030)
Chapter 11. MEA Market
- 11.1. Overview
- 11.2. Market Revenue, by Product (2017-2030)
- 11.3. Market Revenue, by Application (2017-2030)
- 11.4. Market Revenue, by End User (2017-2030)
- 11.5. Market Revenue, by Country (2017-2030)
Chapter 12. U.S. Market
- 12.1. Overview
- 12.2. Market Revenue, by Product (2017-2030)
- 12.3. Market Revenue, by Application (2017-2030)
- 12.4. Market Revenue, by End User (2017-2030)
Chapter 13. Canada Market
- 13.1. Overview
- 13.2. Market Revenue, by Product (2017-2030)
- 13.3. Market Revenue, by Application (2017-2030)
- 13.4. Market Revenue, by End User (2017-2030)
Chapter 14. Germany Market
- 14.1. Overview
- 14.2. Market Revenue, by Product (2017-2030)
- 14.3. Market Revenue, by Application (2017-2030)
- 14.4. Market Revenue, by End User (2017-2030)
Chapter 15. France Market
- 15.1. Overview
- 15.2. Market Revenue, by Product (2017-2030)
- 15.3. Market Revenue, by Application (2017-2030)
- 15.4. Market Revenue, by End User (2017-2030)
Chapter 16. U.K. Market
- 16.1. Overview
- 16.2. Market Revenue, by Product (2017-2030)
- 16.3. Market Revenue, by Application (2017-2030)
- 16.4. Market Revenue, by End User (2017-2030)
Chapter 17. Italy Market
- 17.1. Overview
- 17.2. Market Revenue, by Product (2017-2030)
- 17.3. Market Revenue, by Application (2017-2030)
- 17.4. Market Revenue, by End User (2017-2030)
Chapter 18. Spain Market
- 18.1. Overview
- 18.2. Market Revenue, by Product (2017-2030)
- 18.3. Market Revenue, by Application (2017-2030)
- 18.4. Market Revenue, by End User (2017-2030)
Chapter 19. Japan Market
- 19.1. Overview
- 19.2. Market Revenue, by Product (2017-2030)
- 19.3. Market Revenue, by Application (2017-2030)
- 19.4. Market Revenue, by End User (2017-2030)
Chapter 20. China Market
- 20.1. Overview
- 20.2. Market Revenue, by Product (2017-2030)
- 20.3. Market Revenue, by Application (2017-2030)
- 20.4. Market Revenue, by End User (2017-2030)
Chapter 21. India Market
- 21.1. Overview
- 21.2. Market Revenue, by Product (2017-2030)
- 21.3. Market Revenue, by Application (2017-2030)
- 21.4. Market Revenue, by End User (2017-2030)
Chapter 22. Australia Market
- 22.1. Overview
- 22.2. Market Revenue, by Product (2017-2030)
- 22.3. Market Revenue, by Application (2017-2030)
- 22.4. Market Revenue, by End User (2017-2030)
Chapter 23. South Korea Market
- 23.1. Overview
- 23.2. Market Revenue, by Product (2017-2030)
- 23.3. Market Revenue, by Application (2017-2030)
- 23.4. Market Revenue, by End User (2017-2030)
Chapter 24. Brazil Market
- 24.1. Overview
- 24.2. Market Revenue, by Product (2017-2030)
- 24.3. Market Revenue, by Application (2017-2030)
- 24.4. Market Revenue, by End User (2017-2030)
Chapter 25. Mexico Market
- 25.1. Overview
- 25.2. Market Revenue, by Product (2017-2030)
- 25.3. Market Revenue, by Application (2017-2030)
- 25.4. Market Revenue, by End User (2017-2030)
Chapter 26. Saudi Arabia Market
- 26.1. Overview
- 26.2. Market Revenue, by Product (2017-2030)
- 26.3. Market Revenue, by Application (2017-2030)
- 26.4. Market Revenue, by End User (2017-2030)
Chapter 27. South Africa Market
- 27.1. Overview
- 27.2. Market Revenue, by Product (2017-2030)
- 27.3. Market Revenue, by Application (2017-2030)
- 27.4. Market Revenue, by End User (2017-2030)
Chapter 28. U.A.E. Market
- 28.1. Overview
- 28.2. Market Revenue, by Product (2017-2030)
- 28.3. Market Revenue, by Application (2017-2030)
- 28.4. Market Revenue, by End User (2017-2030)
Chapter 29. Competitive Landscape
- 29.1. List of Market Players and their Offerings
- 29.2. Competitive Benchmarking of Key Players
- 29.3. Product Benchmarking of Key Players
- 29.4. Recent Strategic Developments
Chapter 30. Company Profiles
- 30.1. Medtronic plc.
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
- 30.2. Johnson & Johnson Services Inc.
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
- 30.3. Abbott Laboratories
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
- 30.4. Boston Scientific Corporation
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
- 30.5. Olympus Corporation
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
- 30.6. Stryker Corporation
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
- 30.7. Smith & Nephew plc
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
- 30.8. Varian Medical Systems Inc.
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary
- 30.9. CONMED Corporation
- 30.9.1. Business overview
- 30.9.2. Product and service offerings
- 30.9.3. Key financial summary
- 30.10. AngioDynamics Inc.
- 30.10.1. Business overview
- 30.10.2. Product and service offerings
- 30.10.3. Key financial summary
Chapter 31. Appendix
- 31.1. Abbreviations
- 31.2. Sources and References
- 31.3. Related Reports
